Antimalarial drug policy in Malawi

Annals of Tropical Medicine and Parasitology

Volumn 91, Issue SUPPL. 1, 1997, Pages

  Brabin, B J ^a   Verhoeff, F H ^a   Kazembe, P ^b   Chimsuku, L ^c   Broadhead, R ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b KAMUZU CENTRAL HOSPITAL   (Malawi)

^c UNIVERSITY OF MALAWI   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

ANEMIA; CHILDHOOD MORTALITY; CONFERENCE PAPER; DRUG CHOICE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEALTH CARE POLICY; HUMAN; MALARIA; MALARIA CONTROL; MALAWI; NUTRITION; ONSET AGE; PLASMODIUM FALCIPARUM; PREGNANCY; PRIMIGRAVIDA;

EID: 0030963379     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034983.1997.11813249     Document Type: Conference Paper

References (2)

1. BLOLAND, P. B., LACKRITZ, E. M., KAZEMBE, P. N., WERE, J. B., STEKETEE, R. & CAMPBELL, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 952-937.
2. SLUTSKEV, L., TAYLOR, T. E., WIRIMA, J. J. & STEKETEE, R. W. (1994). In-hospital morbidity and mortality due to malaria-associated severe anaemia in two areas of Malawi with different patterns of malaria infection. Transactions of the Royal Society of Tropical Medicine and Hygiene, 88, 548-551.